• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Neurovalens: Venture Capital Funding History

Neurovalens

To add a bio or update company history, please click update information.

News from Neurovalens

    Neurovalens secures £6m in funding led by Investment Fund for Northern Ireland to expand non-invasive neuro-technologyNeurovalens secures £6m in funding led by Investment Fund for Northern Ireland to expand non-invasive neuro-technology
    Neurovalens
    19 Aug 2025

    Neurovalens secures £6m in funding led by Investment Fund for Northern Ireland to expand non-invasive neuro-technology

    Neurovalens designs non-invasive neurostimulation devices that treat conditions such as insomnia and anxiety, using wearable technology cleared for clinical use.

Neurovalens
  • Health
  • Belfast, United Kingdom
  • £6m
  • neurovalens.com
  • Update Information

More venture news

  • 1nhaler lands a £2m follow-on round led by Archangels to test its pop-up cardboard asthma inhaler in patients
    1nhaler
    3 Nov 2026

    1nhaler lands a £2m follow-on round led by Archangels to test its pop-up cardboard asthma inhaler in patients

    Follow-onHealth
  • XRlabs raises a £6.5m seed round led by Playground Global to embed AI Surgical Intelligence into operating rooms
    XRlabs
    20 Oct 2026

    XRlabs raises a £6.5m seed round led by Playground Global to embed AI Surgical Intelligence into operating rooms

    SeedHealth
  • 1nhaler secures £1.5m in further seed funding led by Archangels to advance its pop-up cardboard inhaler
    1nhaler
    17 Nov 2025

    1nhaler secures £1.5m in further seed funding led by Archangels to advance its pop-up cardboard inhaler

    ExtensionHealth

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn